Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
Gian Paolo Fadini, Enrico Longato, Mario Luca Morieri, Stefano Del Prato et autres
it (code pays fourni par la source)